View Post

Savvy Cooperative: Paid Opportunity for People Diagnosed with Breast Cancer, currently taking Kisqali or Piqray, not living near a large city

In Paid Opportunities For The Cancer Community by Barbara Jacoby

SCREENER Eligibility Criteria: Adult who has been diagnosed with breast cancer Currently taking Kisqali or Piqray Does not live near a big city/ in an urban area NOTE: Only patients with verified diagnoses will be considered US resident Details: 60-minute virtual interview From home Receive: $100 Link: https://gigs.savvy.coop/bcancer/?r=44951 Why Sign Up? Your experiences are so valuable and important to creating …

View Post

Rare Patient Voice: Diffuse Large B Cell Lymphoma Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 25 min Online Survey Compensation $45 Please sign up at the link below for more information or to see if you qualify. http://letlife.in/rare-patient-voice Why Sign up with Rare Patient Voice? Who knows better than you about your journey and experiences?  We connect you with researchers who are developing products and services which can help you and others with …

View Post

New method for scDNA sequencing provides insights into breast cancer evolution

In Clinical Studies News by Barbara Jacoby

Source: University of Texas MD Anderson Cancer Center From: news-medical.net Overcoming previous technical challenges with single-cell DNA (scDNA) sequencing, a group led by researchers at The University of Texas MD Anderson Cancer Center has developed a novel method for scDNA sequencing at single-molecule resolution. This technique revealed for the first time that triple-negative breast cancers undergo continued genetic copy number …

View Post

Prognostic value of molecular classification in metastatic breast cancer confirmed

In In The News by Barbara Jacoby

By: University of Barcelona From: medicalxpress.com Barcelona researchers at the Hospital Clínic-IDIBAPS Research Institute, the University of Barcelona and the SOLTI academic cancer research group have shown that the molecular classification of breast cancer, which divides it into four subtypes (Luminal A, Luminal B, HER2-enriched and Basal-like) is useful for predicting the benefits of treatment in patients with advanced hormone-sensitive …

View Post

Rare Patient Voice: Diffuse large B-cell lymphoma Patients & Caregivers

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 60 min Web-Assisted Phone Interview Compensation $100 Please sign up at the link below for more information or to see if you qualify. http://letlife.in/rare-patient-voice Why Sign up with Rare Patient Voice? Who knows better than you about your journey and experiences?  We connect you with researchers who are developing products and services which can help you and others with …

View Post

Greenwich LifeSciences Presents Immune Response Phase IIb Poster

In Clinical Studies News by Barbara Jacoby

From: businesswire.com Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast Cancer Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today presented a …

View Post

Treatment and outlook for stage 2 breast cancer

In In The News by Barbara Jacoby

Source: healthline.com From: medicalnewstoday.com People with stage 2 breast cancer have cancer cells in their breast tissue, nearby lymph nodes, or both. Stage 2 breast cancer is an early stage of breast cancer in which the cancer has not spread beyond the breast tissue or surrounding lymph nodes. Cancer stages describe the extent to which the cancer has spread and …

View Post

Rare Patient Voice: Prostate Cancer Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 60 min Web-Assisted Phone Interview plus 5 min of homework Compensation $120 Please sign up at the link below for more information or to see if you qualify. http://letlife.in/rare-patient-voice Why Sign up with Rare Patient Voice? Who knows better than you about your journey and experiences?  We connect you with researchers who are developing products and services which can help you …

View Post

Breakthrough Immunotherapy Earns First Regulatory Approval for Triple Negative Breast Cancer

In Clinical Studies News by Barbara Jacoby

From: businesswire.com Immunopheresis™ therapy holds great promise for avoiding serious drawbacks of existing pharmaceuticals and improving patients’ quality of life Immunicom, Inc., a global biotechnology company pioneering novel “subtractive” immunotherapies, today announced that the Immunopheresis™ LW-02 blood-filtering column, its leading immuno-oncology product with FDA Breakthrough Device status, has received regulatory clearance (CE Mark certification) in Europe for use in adults …